PluvEquity: Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer (clinicaltrials.gov) - Oct 7, 2026 - P2 | N=88 | Not yet recruiting | Sponsor: Emory University
New P2 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|